sales@angenesci.com
Login | Register
logo
Structures Search
Home Aminos Sodium 2-(2-amino-3-benzoylphenyl)acetate

Sodium 2-(2-amino-3-benzoylphenyl)acetate

CAS No.:
61941-56-8
Catalog Number:
AG00EKOQ
Molecular Formula:
C15H12NNaO3
Molecular Weight:
277.2505
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
1g
98%
In Stock USA
United States
$62
- +
5g
98%
In Stock USA
United States
$182
- +
10g
98%
In Stock USA
United States
$307
- +
25g
98%
In Stock USA
United States
$613
- +
Product Description
Catalog Number:
AG00EKOQ
Chemical Name:
Sodium 2-(2-amino-3-benzoylphenyl)acetate
CAS Number:
61941-56-8
Molecular Formula:
C15H12NNaO3
Molecular Weight:
277.2505
MDL Number:
MFCD09842317
IUPAC Name:
sodium;2-(2-amino-3-benzoylphenyl)acetate
InChI:
InChI=1S/C15H13NO3.Na/c16-14-11(9-13(17)18)7-4-8-12(14)15(19)10-5-2-1-3-6-10;/h1-8H,9,16H2,(H,17,18);/q;+1/p-1
InChI Key:
MJAQSCHBMPGJES-UHFFFAOYSA-M
SMILES:
[O-]C(=O)Cc1cccc(c1N)C(=O)c1ccccc1.[Na+]
UNII:
C20288EWAG
Properties
Complexity:
342  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
2  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
277.071g/mol
Formal Charge:
0
Heavy Atom Count:
20  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
277.255g/mol
Monoisotopic Mass:
277.071g/mol
Rotatable Bond Count:
4  
Topological Polar Surface Area:
83.2A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
Literature
Title Journal
Randomized clinical trial of treatment for TMJ disc displacement. Journal of dental research 20101101
The effects of nepafenac and amfenac on retinal angiogenesis. Brain research bulletin 20100215
Differential effects of non-steroidal anti-inflammatory drugs on mitochondrial dysfunction during oxidative stress. Archives of biochemistry and biophysics 20091001
Re: Pharmacokinetics and pharmacodynamics of nepafenac, amfenac, ketorolac, and bromfenac. Journal of cataract and refractive surgery 20080801
Amfenac increases the radiosensitivity of uveal melanoma cell lines. Eye (London, England) 20080501
In vivo pharmacokinetics and in vitro pharmacodynamics of nepafenac, amfenac, ketorolac, and bromfenac. Journal of cataract and refractive surgery 20070901
The effect of a selective cyclooxygenase-2 (COX-2) inhibitor on the proliferation rate of retinoblastoma cell lines. Eye (London, England) 20060501
Nepafenac, a unique nonsteroidal prodrug with potential utility in the treatment of trauma-induced ocular inflammation: I. Assessment of anti-inflammatory efficacy. Inflammation 20000801
Antiinflammatory agents. 1. Synthesis and antiinflammatory activity of 2-amino-3-benzoylphenylacetic acid. Journal of medicinal chemistry 19790901
Properties